Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) Monrol 200-2200 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F) in Bulgaria

Product information
, 

Fludeoxyglucose (18F) in Greece

Product information

Fludeoxyglucose (18F) in Romania

Product information

GalenVita

GalenVita 0.74 –3.70 GBq radionuclide generator

Active ingredient

Germanium (68Ge) chloride / gallium (68Ga) chloride

Disease area

Radionuclide Generators

Available in
, 

GalenVita in Austria

Product information
, 
, 

GalenVita in Bulgaria

Product information
, 

GalenVita in Croatia

Product information
, 

GalenVita in Cyprus

Product information
, 

GalenVita in Czech Republic

Product information
, 

GalenVita in Denmark

Product information
, 

GalenVita in Estonia

Product information
, 

GalenVita in Finland

Product information
, 

GalenVita in France

Product information
, 

GalenVita in Germany

Product information
, 

GalenVita in Greece

Product information
, 

GalenVita in Hungary

Product information
, 

GalenVita in Iceland

Product information
, 

GalenVita in Ireland

Product information
, 

GalenVita in Italy

Product information
, 

GalenVita in Latvia

Product information
, 

GalenVita in Liechestein

Product information
, 

GalenVita in Lithuania

Product information
, 

GalenVita in Luxembourg

Product information
, 

GalenVita in Malta

Product information
, 

GalenVita in Netherlands

Product information
, 

GalenVita in Norway

Product information
, 

GalenVita in Poland

Product information
, 

GalenVita in Portugal

Product information
, 

GalenVita in Romania

Product information
, 

GalenVita in Slovakia

Product information
, 

GalenVita in Slovenia

Product information
, 

GalenVita in Spain

Product information

GalenVita in Sweden

Product information

Gallium (67Ga) Citrate

Gallium Citrate Ga 67 Injection

Active ingredient

Gallium citrate Ga 67

Disease area

Infectious Diseases, Oncology, Pulmonology

Available in
, 

Gallium (67Ga) Citrate in Belgium

Product information
, 
, 

Gallium (67Ga) Citrate in Costa Rica

Product information
, 

Gallium (67Ga) Citrate in Czech Republic

Product information
, 

Gallium (67Ga) Citrate in Denmark

Product information
, 

Gallium (67Ga) Citrate in France

Product information
, 

Gallium (67Ga) Citrate in Greece

Product information
, 

Gallium (67Ga) Citrate in Hungary

Product information
, 

Gallium (67Ga) Citrate in International

Product information
, 

Gallium (67Ga) Citrate in Ireland

Product information
, 

Gallium (67Ga) Citrate in Italy

Product information
, 

Gallium (67Ga) Citrate in Netherlands

Product information
, 

Gallium (67Ga) Citrate in Portugal

Product information
, 

Gallium (67Ga) Citrate in Singapore

Product information
, 

Gallium (67Ga) Citrate in Spain

Product information
, 

Gallium (67Ga) Citrate in United Kingdom

Product information

Gallium (67Ga) Citrate in United States

Product information

Indium (111In) Chloride

Indium (111In) Chloride Curiumpharma 370 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-chloride

Disease area

Infectious Diseases, Oncology

Available in
, 

Indium (111In) Chloride in Belgium

Product information
, 

Indium (111In) Chloride in Czech Republic

Product information
, 

Indium (111In) Chloride in Denmark

Product information
, 

Indium (111In) Chloride in Finland

Product information
, 

Indium (111In) Chloride in France

Product information
, 

Indium (111In) Chloride in Greece

Product information
, 

Indium (111In) Chloride in Ireland

Product information
, 

Indium (111In) Chloride in Netherlands

Product information
, 

Indium (111In) Chloride in Norway

Product information
, 

Indium (111In) Chloride in Singapore

Product information
, 

Indium (111In) Chloride in Spain

Product information
, 

Indium (111In) Chloride in Sweden

Product information
, 

Indium (111In) Chloride in Switzerland

Product information

Indium (111In) Chloride in United Kingdom

Product information

Indium (111In) DTPA

Indium (111In) DTPA 37 MBq/mL solution for injection

Active ingredient

In111-pentetate

Disease area

Neurology

Available in
, 

Indium (111In) DTPA in Belgium

Product information
, 

Indium (111In) DTPA in Czech Republic

Product information
, 

Indium (111In) DTPA in Denmark

Product information
, 

Indium (111In) DTPA in Finland

Product information
, 

Indium (111In) DTPA in France

Product information
, 

Indium (111In) DTPA in Germany

Product information
, 

Indium (111In) DTPA in Greece

Product information
, 

Indium (111In) DTPA in Ireland

Product information
, 

Indium (111In) DTPA in Italy

Product information
, 

Indium (111In) DTPA in Netherlands

Product information
, 

Indium (111In) DTPA in Spain

Product information

Indium (111In) DTPA in United Kingdom

Product information

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Austria

Product information
, 

Octreoscan™ in Belgium

Product information
, 

Octreoscan™ in Czech Republic

Product information
, 

Octreoscan™ in Denmark

Product information
, 

Octreoscan™ in France

Product information
, 

Octreoscan™ in Germany

Product information
, 

Octreoscan™ in Greece

Product information
, 

Octreoscan™ in Hungary

Product information
, 

Octreoscan™ in International

Product information
, 

Octreoscan™ in Ireland

Product information
, 

Octreoscan™ in Italy

Product information
, 

Octreoscan™ in Mexico

Product information
, 

Octreoscan™ in Netherlands

Product information
, 

Octreoscan™ in Portugal

Product information
, 

Octreoscan™ in Republic of Korea

Product information
, 

Octreoscan™ in Singapore

Product information
, 

Octreoscan™ in Slovakia

Product information
, 

Octreoscan™ in Spain

Product information
, 

Octreoscan™ in Sweden

Product information
, 

Octreoscan™ in United Kingdom

Product information

Octreoscan™ in United States

Product information

Pulmocis®

Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation

Active ingredient

macroaggregated human albumin (macrosalb)

Disease area

Pulmonology

Available in
, 

Pulmocis® in Austria

Product information
, 

Pulmocis® in Belgium

Product information
, 

Pulmocis® in Colombia

Product information
, 

Pulmocis® in Croatia

Product information
, 

Pulmocis® in Czech Republic

Product information
, 

Pulmocis® in Denmark

Product information
, 

Pulmocis® in Finland

Product information
, 

Pulmocis® in France

Product information
, 

Pulmocis® in Germany

Product information
, 

Pulmocis® in Greece

Product information
, 

Pulmocis® in International

Product information
, 

Pulmocis® in Ireland

Product information
, 

Pulmocis® in Italy

Product information
, 

Pulmocis® in Luxembourg

Product information
, 

Pulmocis® in Malta

Product information
, 

Pulmocis® in Netherlands

Product information
, 

Pulmocis® in Norway

Product information
, 

Pulmocis® in Portugal

Product information
, 

Pulmocis® in Slovakia

Product information
, 

Pulmocis® in Slovenia

Product information
, 

Pulmocis® in Spain

Product information
, 

Pulmocis® in Sweden

Product information

Pulmocis® in United Kingdom

Product information

PYLCLARI®

PYLCLARI®

Active ingredient

Piflufolastat (18F)

Disease area

Oncology

Available in
, 

PYLCLARI® in Austria

Product information
, 

PYLCLARI® in Bulgaria

Product information
, 

PYLCLARI® in Croatia

Product information
, 

PYLCLARI® in Czech Republic

Product information
, 

PYLCLARI® in Denmark

Product information
, 

PYLCLARI® in Estonia

Product information
, 

PYLCLARI® in Finland

Product information
, 

PYLCLARI® in France

Product information
, 

PYLCLARI® in Germany

Product information
, 

PYLCLARI® in Greece

Product information
, 

PYLCLARI® in Hungary

Product information
, 

PYLCLARI® in Iceland

Product information
, 

PYLCLARI® in Italy

Product information
, 

PYLCLARI® in Latvia

Product information
, 

PYLCLARI® in Lithuania

Product information
, 

PYLCLARI® in Malta

Product information
, 

PYLCLARI® in Netherlands

Product information
, 

PYLCLARI® in Norway

Product information
, 

PYLCLARI® in Poland

Product information
, 

PYLCLARI® in Portugal

Product information
, 

PYLCLARI® in Romania

Product information
, 

PYLCLARI® in Slovakia

Product information
, 

PYLCLARI® in Slovenia

Product information
, 

PYLCLARI® in Spain

Product information

PYLCLARI® in Sweden

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Renocis®

kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Renocis® in Colombia

Product information
, 

Renocis® in Denmark

Product information
, 

Renocis® in Finland

Product information
, 

Renocis® in France

Product information
, 

Renocis® in Greece

Product information
, 

Renocis® in International

Product information
, 

Renocis® in Ireland

Product information
, 

Renocis® in Italy

Product information
, 

Renocis® in Peru

Product information
, 

Renocis® in Portugal

Product information
, 

Renocis® in Spain

Product information
, 

Renocis® in Sweden

Product information

Renocis® in United Kingdom

Product information

Sodium iodide (¹³¹I)

MONIYOT-131 Capsule T 37-7400 MBq hard capsule for therapeutic use

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) in Denmark

Product information
, 

Sodium iodide (¹³¹I) in Germany

Product information
, 

Sodium iodide (¹³¹I) in Greece

Product information

Sodium iodide (¹³¹I) in Romania

Product information

Sodium iodide (¹³¹I) – oral solution

MONIYOT-131 14.8–3700 MBq/mL oral solution

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) – oral solution in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Denmark

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Germany

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Greece

Product information

Sodium iodide (¹³¹I) – oral solution in Romania

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Australia

Product information
, 

Stamicis® in Austria

Product information
, 

Stamicis® in Belgium

Product information
, 

Stamicis® in Colombia

Product information
, 

Stamicis® in Czech Republic

Product information
, 

Stamicis® in Denmark

Product information
, 

Stamicis® in Finland

Product information
, 

Stamicis® in France

Product information
, 

Stamicis® in Germany

Product information
, 

Stamicis® in Greece

Product information
, 

Stamicis® in India

Product information
, 

Stamicis® in International

Product information
, 

Stamicis® in Ireland

Product information
, 

Stamicis® in Israel

Product information
, 

Stamicis® in Italy

Product information
, 

Stamicis® in Luxembourg

Product information
, 

Stamicis® in Netherlands

Product information
, 

Stamicis® in Norway

Product information
, 

Stamicis® in Peru

Product information
, 

Stamicis® in Portugal

Product information
, 

Stamicis® in Republic of Korea

Product information
, 

Stamicis® in Singapore

Product information
, 

Stamicis® in Slovakia

Product information
, 

Stamicis® in Slovenia

Product information
, 

Stamicis® in Spain

Product information
, 

Stamicis® in Sweden

Product information
, 

Stamicis® in Switzerland

Product information

Stamicis® in United Kingdom

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Austria

Product information
, 

Striascan™ in Belgium

Product information
, 

Striascan™ in Bulgaria

Product information
, 

Striascan™ in Croatia

Product information
, 

Striascan™ in Cyprus

Product information
, 

Striascan™ in Czech Republic

Product information
, 

Striascan™ in Denmark

Product information
, 

Striascan™ in Estonia

Product information
, 

Striascan™ in Finland

Product information
, 

Striascan™ in France

Product information
, 

Striascan™ in Germany

Product information
, 

Striascan™ in Greece

Product information
, 

Striascan™ in Hungary

Product information
, 

Striascan™ in Iceland

Product information
, 

Striascan™ in International

Product information
, 

Striascan™ in Ireland

Product information
, 

Striascan™ in Italy

Product information
, 

Striascan™ in Latvia

Product information
, 

Striascan™ in Lithuania

Product information
, 

Striascan™ in Luxembourg

Product information
, 

Striascan™ in Malta

Product information
, 

Striascan™ in Netherlands

Product information
, 

Striascan™ in Norway

Product information
, 

Striascan™ in Poland

Product information
, 

Striascan™ in Portugal

Product information
, 

Striascan™ in Romania

Product information
, 

Striascan™ in Slovakia

Product information
, 

Striascan™ in Slovenia

Product information
, 

Striascan™ in Spain

Product information
, 

Striascan™ in Sweden

Product information
, 

Striascan™ in Switzerland

Product information
, 

Striascan™ in Turkey

Product information

Striascan™ in United Kingdom

Product information

Teceos®

Teceos 13 mg kit for radiopharmaceutical preparation

Active ingredient

Butedronate tetrasodium

Disease area

Cardiology, Oncology

Available in
, 

Teceos® in Austria

Product information
, 

Teceos® in Denmark

Product information
, 

Teceos® in Finland

Product information
, 

Teceos® in France

Product information
, 

Teceos® in Germany

Product information
, 

Teceos® in Greece

Product information
, 

Teceos® in International

Product information
, 

Teceos® in Mexico

Product information
, 

Teceos® in Netherlands

Product information
, 

Teceos® in Norway

Product information
, 

Teceos® in Republic of Korea

Product information
, 

Teceos® in Spain

Product information
, 

Teceos® in Sweden

Product information

Teceos® in Switzerland

Product information

Technescan™ DMSA

Technescan DMSA 1.2 mg kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Technescan™ DMSA in Austria

Product information
, 

Technescan™ DMSA in Belgium

Product information
, 

Technescan™ DMSA in Czech Republic

Product information
, 

Technescan™ DMSA in Denmark

Product information
, 

Technescan™ DMSA in Finland

Product information
, 

Technescan™ DMSA in France

Product information
, 

Technescan™ DMSA in Germany

Product information
, 

Technescan™ DMSA in Greece

Product information
, 

Technescan™ DMSA in Hungary

Product information
, 

Technescan™ DMSA in Ireland

Product information
, 

Technescan™ DMSA in Malaysia

Product information
, 

Technescan™ DMSA in Netherlands

Product information
, 

Technescan™ DMSA in Norway

Product information
, 

Technescan™ DMSA in Republic of Korea

Product information
, 

Technescan™ DMSA in Romania

Product information
, 

Technescan™ DMSA in Slovakia

Product information
, 

Technescan™ DMSA in Spain

Product information
, 

Technescan™ DMSA in Sweden

Product information

Technescan™ DMSA in Switzerland

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Austria

Product information
, 

Technescan™ MAG3 in Belgium

Product information
, 

Technescan™ MAG3 in Colombia

Product information
, 

Technescan™ MAG3 in Czech Republic

Product information
, 

Technescan™ MAG3 in Denmark

Product information
, 

Technescan™ MAG3 in Finland

Product information
, 

Technescan™ MAG3 in France

Product information
, 

Technescan™ MAG3 in Germany

Product information
, 

Technescan™ MAG3 in Greece

Product information
, 

Technescan™ MAG3 in Hungary

Product information
, 

Technescan™ MAG3 in Ireland

Product information
, 

Technescan™ MAG3 in Italy

Product information
, 

Technescan™ MAG3 in Malaysia

Product information
, 

Technescan™ MAG3 in Mexico

Product information
, 

Technescan™ MAG3 in Netherlands

Product information
, 

Technescan™ MAG3 in Norway

Product information
, 

Technescan™ MAG3 in Peru

Product information
, 

Technescan™ MAG3 in Portugal

Product information
, 

Technescan™ MAG3 in Republic of Korea

Product information
, 

Technescan™ MAG3 in Slovakia

Product information
, 

Technescan™ MAG3 in Spain

Product information
, 

Technescan™ MAG3 in Sweden

Product information
, 

Technescan™ MAG3 in Switzerland

Product information
, 

Technescan™ MAG3 in Turkey

Product information

Technescan™ MAG3 in United Kingdom

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Technetium-99m generator

MONTEK 10-40 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Technetium-99m generator in Austria

Product information
, 

Technetium-99m generator in Belgium

Product information
, 

Technetium-99m generator in Bulgaria

Product information
, 

Technetium-99m generator in Denmark

Product information
, 

Technetium-99m generator in France

Product information
, 

Technetium-99m generator in Germany

Product information
, 

Technetium-99m generator in Greece

Product information
, 

Technetium-99m generator in Hungary

Product information
, 

Technetium-99m generator in Italy

Product information
, 

Technetium-99m generator in Netherlands

Product information
, 

Technetium-99m generator in Poland

Product information
, 

Technetium-99m generator in Portugal

Product information
, 

Technetium-99m generator in Romania

Product information

Technetium-99m generator in Spain

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Austria

Product information
, 

Ultra Technekow™ FM in Belgium

Product information
, 

Ultra Technekow™ FM in Bosnia

Product information
, 

Ultra Technekow™ FM in Colombia

Product information
, 

Ultra Technekow™ FM in Costa Rica

Product information
, 

Ultra Technekow™ FM in Cyprus

Product information
, 

Ultra Technekow™ FM in Czech Republic

Product information
, 

Ultra Technekow™ FM in Denmark

Product information
, 

Ultra Technekow™ FM in Dominican Republic

Product information
, 

Ultra Technekow™ FM in Finland

Product information
, 

Ultra Technekow™ FM in France

Product information
, 

Ultra Technekow™ FM in Germany

Product information
, 

Ultra Technekow™ FM in Greece

Product information
, 

Ultra Technekow™ FM in Hong Kong

Product information
, 

Ultra Technekow™ FM in Hungary

Product information
, 

Ultra Technekow™ FM in India

Product information
, 

Ultra Technekow™ FM in Ireland

Product information
, 

Ultra Technekow™ FM in Italy

Product information
, 

Ultra Technekow™ FM in Luxembourg

Product information
, 

Ultra Technekow™ FM in Malaysia

Product information
, 

Ultra Technekow™ FM in Moldova

Product information
, 

Ultra Technekow™ FM in Netherlands

Product information
, 

Ultra Technekow™ FM in Norway

Product information
, 

Ultra Technekow™ FM in Peru

Product information
, 

Ultra Technekow™ FM in Poland

Product information
, 

Ultra Technekow™ FM in Portugal

Product information
, 

Ultra Technekow™ FM in Republic of Korea

Product information
, 

Ultra Technekow™ FM in Romania

Product information
, 

Ultra Technekow™ FM in Serbia

Product information
, 

Ultra Technekow™ FM in Singapore

Product information
, 

Ultra Technekow™ FM in Slovakia

Product information
, 

Ultra Technekow™ FM in Spain

Product information
, 

Ultra Technekow™ FM in Sweden

Product information
, 

Ultra Technekow™ FM in Switzerland

Product information
, 

Ultra Technekow™ FM in Turkey

Product information

Ultra Technekow™ FM in United Kingdom

Product information